Decreasing brain natriuretic peptide levels after treatment for hyperthyroidism

Area of Science:

• Cardiology
• Endocrinology
• Biochemistry

Background:

• B-type natriuretic peptide (BNP) is produced by ventricular cardiomyocytes in response to cardiac stress.
• Elevated BNP levels are a key indicator for diagnosing heart failure.
• Thyroid hormones influence cardiovascular function, but their direct impact on BNP levels requires further elucidation.

Purpose of the Study:

• To evaluate B-type natriuretic peptide (BNP) levels in patients with overt hyperthyroidism before and after achieving euthyroidism.
• To investigate the correlation between thyroid hormone levels (fT3, fT4, TSH) and BNP levels in hyperthyroid patients.

Main Methods:

• Prospective study of 48 newly diagnosed, untreated hyperthyroid patients.
• Measurement of thyroid hormones (fT3, fT4, TSH) and BNP levels before treatment and after achieving euthyroidism.
• Transthoracic echocardiography was performed on all subjects.

Main Results:

• A statistically significant decrease in BNP levels was observed after achieving euthyroidism (102.5 ng/L vs. 5.0 ng/L, p<0.001).
• The reduction in BNP levels showed a positive correlation with the decrease in fT3 (r=0.298; p=0.049) and fT4 (r=0.313; p=0.030).
• No significant correlation was found between BNP levels and TSH levels.

Conclusions:

• Hyperthyroidism can lead to elevated BNP levels, potentially causing misdiagnosis of congestive heart failure.
• Checking thyroid hormone levels is recommended for patients presenting with high BNP measurements.
• Thyroid hormone status is a critical factor to consider in the interpretation of BNP levels.